Navigation Links
Global Anticoagulants Industry
Date:12/5/2012

tly Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-23

 

Table 35: European Historic Review for Anticoagulants by

Geographic Region / Country - France, Germany, Italy, UK,

Spain, and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2004

through 2009 (includes corresponding Graph/Chart) III-24

 

Table 36: European 15-Year Perspective for Anticoagulants by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, Italy, UK, Spain, and Rest of Europe

Markets for Years 2004, 2011 & 2018 (includes corresponding

Graph/Chart) III-25

 

Table 37: European Recent Past, Current & Future Analysis

for Anticoagulants by Product Segment - Oral Anticoagulants

and Injectable Anticoagulants (Unfractionated Heparin and

Low Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-26

 

Table 38: European Historic Review for Anticoagulants by

Product Segment - Oral Anticoagulants and Injectable

Anticoagulants (Unfractionated Heparin and Low Molecular

Weight Heparin) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2004 through 2009

(includes corresponding Graph/Chart) III-27

 

Table 39: European 15-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) III-28

 

3a. FRANCE III-29

A.Mark
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Global Operating Tables Industry
2. Global Proteomics Industry
3. Global Neurostimulation Industry
4. Global Audiological Devices Industry
5. Global Condoms Industry
6. Sophono Names Global Sales and Marketing Vice President
7. Global Chitin and Chitosan Industry
8. Global Sleep Apnea Diagnostic And Therapeutic Devices Industry
9. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
10. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
11. Global Bioinformatics Market is Expected to Reach USD 9.1 Billion in 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 AARP Foundation today announced it has ... suffering from the severe cold weather that has gripped much ... helping those in need; so to support these emergency relief ... to $250,000, which could mean up to $500,000 in aid. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 15, 2014  In an unprecedented effort to curb the spread of ... other transport vehicles, an advanced and portable UV germicidal lamp manufactured ... first time. In order to prevent EMS paramedics ... West Palm Beach Fire Rescue is the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... Nov. 1, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering and developing breakthrough treatments for human disease, ... results for the three and nine months ended September ... studies of LX4211 and LX1032 have provided further validation ...
... BEIJING, Nov. 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... leading China-based advanced in-vitro diagnostic ("IVD") company, today announced ... the second fiscal quarter ended September 30, 2011 ("2Q ... 2011. The Company,s senior management will host ...
Cached Medicine Technology:Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 2Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 3Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 4Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 5Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 6Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 7Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 8China Medical Technologies to Announce Results for the Second Fiscal Quarter Ended September 30, 2011 on November 18, 2011 2
(Date:4/18/2014)... worst memories? How did it make you feel? According ... personal experience, such as how sad you were or ... especially when you can,t stop thinking about it. ... the context of the memories, rather than how you ... alleviate the negative effects of these memories, a new ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... Ill. One of the most popular vaccine brands ... And doctors may be overlooking some cost factors when ... a more expensive option, according to a new study ... vaccines to administer can be driven by numerous factors," ... and a professor of computer science and of mathematics ...
(Date:4/17/2014)... review published in the April issue of Immunity ... Institute for Medical Research, says it,s time to take ... to treating sepsis, which kills millions worldwide every ... when molecules released into the bloodstream to fight an ... is necessary for maintaining good health without inflammation, ...
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
Breaking Medicine News(10 mins):Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2
... Gathers Record Attendance for Annual ... ... for the Cure(R), the,world,s largest and most progressive grassroots network of ... 7-9 at the Hilton Anatole in Dallas. The three-day event,brings together ...
... chances , , THURSDAY, Feb. 7 (HealthDay News) -- Women ... becoming pregnant by up to 65 percent if they ... About 10 percent to 15 percent of couples have ... in which a woman,s egg is fertilized in a ...
... corrects flaws in existing policy; Legislation has,overwhelming support ... 7 Next week, the House,Committee on Foreign ... and Malaria Reauthorization Act of 2008 - funding ... AIDS Relief,(PEPFAR). A coalition of more than 160 ...
... cells cheat death without unwanted side effects , ... has recently been shown to protect cells in the nervous ... this regard is limited, because it also induces blood vessel ... Xuri Li and colleagues at the National Institutes of Health, ...
... Patients with a certain gene variant drank less ... without the variant while taking the medication naltrexone, ... National Institutes of Health,s 2001-2004 COMBINE (Combined Pharmacotherapies ... About 87 percent of patients with the variant ...
... First Year of Growth in Past Three Years and Fourth Consecutive ... Revenue Increase ... the innovator and leader of BioZ(R) Impedance Cardiography (ICG),technology, today reported ... for the ICG business and do not include,results for Vermed which ...
Cached Medicine News:Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 2Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 3Health News:Acupuncture May Aid In Vitro Fertilization 2Health News:Acupuncture May Aid In Vitro Fertilization 3Health News:Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs 2Health News:Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs 3Health News:JCI online early table of contents: Feb. 7, 2008 2Health News:JCI online early table of contents: Feb. 7, 2008 3Health News:JCI online early table of contents: Feb. 7, 2008 4Health News:JCI online early table of contents: Feb. 7, 2008 5Health News:JCI online early table of contents: Feb. 7, 2008 6Health News:JCI online early table of contents: Feb. 7, 2008 7Health News:JCI online early table of contents: Feb. 7, 2008 8Health News:Gene variant predicts medication response in patients with alcohol dependence 2Health News:Gene variant predicts medication response in patients with alcohol dependence 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 4Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 5Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 6Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: